1. Home
  2. BCDA vs SFHG Comparison

BCDA vs SFHG Comparison

Compare BCDA & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCDA

BioCardia Inc.

HOLD

Current Price

$0.97

Market Cap

11.8M

Sector

Health Care

ML Signal

HOLD

SFHG

Samfine Creation Holdings Group Limited Ordinary Share

HOLD

Current Price

$2.45

Market Cap

10.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCDA
SFHG
Founded
N/A
1993
Country
United States
Hong Kong
Employees
21
226
Industry
Biotechnology: Pharmaceutical Preparations
Publishing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
10.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BCDA
SFHG
Price
$0.97
$2.45
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
6.5M
23.5K
Earning Date
05-13-2026
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.78
$0.32
52 Week High
$2.45
$3.17

Technical Indicators

Market Signals
Indicator
BCDA
SFHG
Relative Strength Index (RSI) 51.26 48.68
Support Level $0.81 $2.26
Resistance Level $1.36 $2.60
Average True Range (ATR) 0.14 0.22
MACD 0.02 0.00
Stochastic Oscillator 17.74 33.79

Price Performance

Historical Comparison
BCDA
SFHG

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

Share on Social Networks: